The rapid increase of rapid microbial testing - Market to reach $19.5 billion by 2022
The pharmaceutical microbiology market is wide open and receptive to advancing rapid diagnostic technologies to improve patient management, exponential population growth and aging conventional technology will only intensify the pace of development. In light of this development, SMi's pharmaceutical Microbiology East Coast conference will shed insight onto the current designed therapies and rapid microbial detection trends.
SMi is pleased to have Founder & CEO of ImmuneBiotech AB, Shahram Lavasani presenting one of this year's Rapid Microbial spotlight sessions. Shahram's talk will focus on how the gut microbiome plays an essential role in disease regulation and efficacy of therapies, whilst assessing how altered microbial communities, also termed dysbiosis, have been observed in many intestinal and extra-intestinal inflammatory disorders. There is not yet a clear understanding whether dysbiosis is a cause or a consequence of the diseases. Microbial therapies which only target the dysbiosis have shown limited success.
The importance of multiple-target drug cocktails comprising commensal bacteria will also be a topic of discussion, along with an evaluation of how the bacterial library, screening technologies and design of potential and affordable drugs will be presented with particular focus on successful products that treat Irritable Bowel Syndrome (IBS) and Clostridium Difficile Infection.
For more on information on this year's selection of hot topics, visit the Pharmaceutical Microbiology East Coast website at http://www.microbiologyeastcoast.com/openpr
This year’s conference will gather a global audience of scientific leaders, funding bodies and drug development experts, providing a focal point to discuss funding opportunities and clinical advancements in microbial control strategies and quality methods.
The notable speaker line-up at Pharmaceutical Microbiology East Coast will also include Microbiology Consulting, LLC, Genentech, GlaxoSmithKline, Johnson & Johnson, Eli Lily, Sanofi Pasteur and many more!
For those wanting to attend, there is currently a manager’s special offer available; book by September 15th, 2017 to save $800 off the conference price. Register at www.microbiologyeastcoast.com/openpr
Pharmaceutical Microbiology East Coast 2017 is sponsored by Associates of Cape Cod, Inc. BioMérieux and Charles River.
For sponsorship packages: Contact Alia Malick +44 (0) 207 827 6168 or e-mail email@example.com.
For delegate enquiries: Contact Sean Vaghela on +44 (0) 20 7827 6744 or email firstname.lastname@example.org
For media enquiries, contact Kyra Williams on +44 (0) 20 7827 6012 or email email@example.com
Pharmaceutical Microbiology East Coast
November 13 – 14, 2017
Iselin, New Jersey, USA
Contact e-mail: firstname.lastname@example.org
Contact tel: +44 (0) 207 827 6012
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
1 Westminister Bridge Road,
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The rapid increase of rapid microbial testing - Market to reach $19.5 billion by 2022 here
News-ID: 701274 • Views: 641
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The
More Releases for Microbiology
Microbiology Testing/Clinical Microbiology Market: Future Innovations, Growth El …
The latest Microbiology Testing/Clinical Microbiology Market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thoroughanalysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. This study can be described as most wide-ranging documentation that comprises all the aspects of the evolving Microbiology Testing/Clinical
Microbiology Testing or Clinical Microbiology Market Size, Share, Trends, Analys …
The Global Microbiology Testing or Clinical Microbiology Market is poised to value over USD 9.2 billion by 2027 end at a CAGR of over 10.6% during the forecast period 2020 to 2027. Microbiology Testing or Clinical Microbiology report provides a comprehensive analysis of competitive factors, consumer behavior, growth trends, product utilization, competitive analysis, brand positioning, and price patterns. Detailed pricing patterns are obtained by studying both the prices of major players
Conference Series LLC LTD, the world's leading Scientific Event Organizer invites all the Speakers, Delegates, Researchers, Students and Industrialists to attend 49th World Congress on Microbiology (Microbiology Webinar) on June 15 around the theme Fostering developments and applications in Microbiology. URL: https://europe.microbiologyconferences.com/ Microbiology 2020 webinar is a unique and exciting opportunity, have been designed in an interdisciplinary manner with a multitude of tracks to showcase the latest advancements and new
International Conference on Microbiology
We take immense pleasure to invite the participants from all over the world to attend "International Conference on Microbiology" during November 11-12, 2020 Tokyo, Japan with the theme "Recent advances in Microbiology" which includes Keynote presentations, Oral talks, Poster presentations and Exhibitions. The conference will majorly highlight the recent advances in the field of Microbiology. The aim of our conference is to provide an opportunity to exchange knowledge, expertise along with
Global Medical Microbiology Testing Technologies Market: Demand for Automation i …
Rapid identification of microorganisms in medical microbiology can be of great value for selection of ideal treatments for patients for infections caused by bacteria, viruses, fungus, mycobacterium, and parasites. It enables actual reduction from conventional broad spectrum antimicrobial agents to specific targeted antimicrobial therapy. The various advantages associated with medical microbiology testing technologies over conventional manual systems, such as automated microscopy and serological testing have been the primary growth drivers
Microbiology Testing Industry Demand for Automation in Microbiology Research Ass …
Microbiology testing Application: Microbiology testing is majorly used in pharmaceuticals/medical, food and beverages market, energy and in cosmetics market. The products such as Aqua Plate, Real-time PCR, food pathogen system, etc. are being used by laboratories to test water contamination, pharmaceuticals and food samples. Various methods such as culture testing method or food pathogen test are used to perform microbial testing on the microbial samples. Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/697 Key